24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

All regions

Cancer Industry, November 2014 Market Reports from Top Publishers

You might be interested in: Medical Equipment, Therapeutics, Drug, more »


 
1-20 of about 141 000 reports for Cancer

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

... A snapshot of the global therapeutic landscape of adrenocortical carcinoma (adrenal cortex cancer)- the report reviews key pipeline products under drug profile section which includes, product description ...

Agennix AG (Symbol:AGX) SWOT Analysis, Strategy, Revenues and Profits

Agennix AG (Symbol:AGX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Include topical talactoferrin, rgb-286638 multi targeted kinase inhibitor and satraplatin. The company provides products for the treatment of lung cancer, prostate cancer, renal cancer, solid tumors ...

ALIGN Pharmaceuticals, LLC. SWOT Analysis, Strategy, Revenues and Profits

ALIGN Pharmaceuticals, LLC. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Patient population suffering from xerostomia and radiation dermatitis. These products provide relief to cancer patients undergoing radiation therapy or chemotherapy and patients suffering from sjogren ...

Patrys Limited (Symbol:PAB) SWOT Analysis, Strategy, Revenues and Profits

Patrys Limited (Symbol:PAB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... And pat-lm1 used to treat multiple cancers; and pats-nm2/pm2/ba3/ba4 and pats-nm1/pm1/cm1/cm2 are used to treat other cancers. Patrys' pipeline consists of antibodies at different stages of early ...

PhytoHealth Corporation (Symbol:4108) SWOT Analysis, Strategy, Revenues and Profits

PhytoHealth Corporation (Symbol:4108) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Under clinical development include phn031, phn033, phn013, phn131, phn014, and phn015. The company launched its phn012 product for cancer related fatigue. It offers products in the areas of cancer related ...

PhytoMedical Technologies, Inc. (Symbol:PYTO) SWOT Analysis, Strategy, Revenues and Profits

PhytoMedical Technologies, Inc. (Symbol:PYTO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... And is currently developing innovative treatments for cancer in collaboration with scientists at dartmouth college. Its partnership with the iowa state university has enabled scientists to synthesize a compound ...

VioQuest Pharmaceuticals, Inc. (VOQP) - Strategic SWOT Analysis Review

VioQuest Pharmaceuticals, Inc. (VOQP) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... The pharmaceutical and medical solutions. The company is dedicated to successful development of novel drug therapies targeting both the molecular basis of cancer and side effects of treatment. Vioquest's oncology ...

CUREXO, INC. (Symbol:060280) SWOT Analysis, Strategy, Revenues and Profits

CUREXO, INC. (Symbol:060280) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Directed surgical robotic system, endosector breast cancer surgery system and dds drug delivery systems. The company conducts its operations across the us and south korea. It conducts the development, manufacture ...

Janssen-Cilag Gmbh SWOT Analysis, Strategy, Revenues and Profits

Janssen-Cilag Gmbh SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Medicine. Janssen-cilag's therapeutic areas include, adhd, asthma, hiv/aids, anemia in cancer, dementia, anemia in kidney disease, migraine, psoriasis, urology, schizophrenia, epilepsy, multiple myeloma ...

MetrioPharm AG (Symbol:MP5) SWOT Analysis, Strategy, Revenues and Profits

MetrioPharm AG (Symbol:MP5) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... It develops drugs for inflammatory, infective, auto-immune diseases, cancer and alzheimer disease. Metriopharm's drug compounds are used in clinical applications such as bacterial infections, hepatitis (b ...

About 15 000 reports for Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2013
    64 pages
  • Cancer  

  • United States  

    North America  

View report >

91 Companies for Cancer

Read our Company Profiles

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

Eli Lilly and Co.

United States

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.